HEStaff exchange2025–2028

BIOCOCOMER · BIOMOLECULAR CONDENSATES AND COACERVATES: FROM MEDICINE TO AGRICULTURE

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2025-01-01 → 2028-12-31
EU contribution
€1,154,600
Participants
11
Scheme
HORIZON-TMA-MSCA-SE

Lines connect the coordinator with its partners.

Project objective

BIOCOCOMER will pursue three general objectives, (Research&Innovation, Training, and International Collaboration) that will be achieved through the development of new skills and products and exchange of multidisciplinary and complementary knowledge and competences within the international Partners from Italy, Australia, Portugal, Spain, Cuba, Switzerland, Germany and South Korea. Research and Innovation Objectives: Objective 1 Engineering and Characterising biomolecular functional condensates and coacervatesObjective 2 Understanding the behavior of the bioactive coacervates in cellular environments Objective 3 Application of coacervates in gene editing of recalcitrant plantsTowards innovative tools for gene delivery in organisms, BIOCOCOMER is focused on the design and engineering of innovative biomolecular condensates/coacervates using peptides, proteins, polysaccharide and nucleic acids, as innovative tools for gene delivery in mammalian cells and plants. Through a combination of computer-based theoretical design and experimental and characterization approaches BIOCOCOMER is expected to generate a library of well-defined condensates and coacervates by programmed co-assembly and phase separation of mixtures of biomacromolecules, i.e polysaccharide-protein, polysaccharide-polyphenols, peptide-peptide, nucleic acid-protein. The condensates and coacervates will be engineered to readily recruit RNA and DNA molecules during phase separation in aqueous solution and to be stimuli responsive to enable transfection of mammalian cells and plants. Scientific Impact: BIOCOCOMER will ultimately result in significant scientific breakthroughs towards innovative universal transfection tools with widespread biomedical and biotechnological applications. We intend to explore the potential of the developed platforms with the long-term aim of boosting the translational pathway of research in medicine and agriculture.

Original text from CORDIS.

Participants

  • UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA · RomaCoordinatorItaly
  • CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA · La HabanaCuba
  • GYEONGSANG NATIONAL UNIVERSITY · JINJU-SISouth Korea
  • INNO-SOL SOCIETA A RESPONSABILITA LIMITATA START-UP INNOVATIVA · ROMAItaly
  • INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY · BragaPortugal
  • LEIBNIZ-INSTITUT FUR POLYMERFORSCHUNG DRESDEN EV · DresdenGermany
  • ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY*RMIT UNIVERSITY · MelbourneAustralia
  • UNIVERSIDAD DE VIGO · VIGO PONTEVEDRASpain
  • UNIVERSITA DEGLI STUDI DI PADOVA · PadovaItaly
  • UNIVERSITE DE FRIBOURG · FribourgSwitzerland
  • UNIVERSITY OF MELBOURNE · MelbourneAustralia

Links

Data: CORDIS, © European Union